ASX Filings

Quarterly Activities/Appendix 4C Cash Flow Report

April 30, 2024

Opthea Presents at the OIS Retina Innovation Summit at ARVO

April 26, 2024

Notification regarding unquoted securities - OPT

April 15, 2024

Notification regarding unquoted securities - OPT

April 15, 2024

Opthea Appoints John Han, PharmD, as VP Medical Affairs

April 9, 2024

Opthea Corporate Presentation - April 2024

April 5, 2024

Opteha to Participate in the 23rd Needham Virtual Conference

April 5, 2024

Final Director's Interest Notice DS

April 4, 2024

Initial Director's Interest Notice Sujal Shah

April 4, 2024

Opthea Appoints Sujal Shah to the Board of Directors

April 4, 2024